Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.26 HKD | +0.72% |
|
-2.43% | -61.96% |
Jun. 27 | Bank of China Downgrades Wuxi Biologics (Cayman) to Hold From Buy, Price Target is HK$14 | MT |
Jun. 19 | Wuxi Biologics Terms US Plant's Expansion Halt as Normal Business Adjustment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-61.96% | 5.98B | |
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.56B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |
- Stock Market
- Equities
- 2269 Stock
- News WuXi Biologics (Cayman) Inc.
- Nomura Adjusts Wuxi Biologics' Price Target to HK$53.65 From HK$58.44, Keeps at Buy